Global Biologics CDMO Market Research Report 2023-2033: Biologics Revolutionizes Treatments, Complex Biologic Molecules Drive Demand for CDMO Services
December 06, 2023 03:23 ET
|
Research and Markets
Dublin, Dec. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Biologics CDMO Market - A Global and Regional Analysis, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The global...
TCR-Therapy Pipeline Research Report 2023: Comprehensive Insights on 30+ Companies and 100+ Pipeline Drugs
November 22, 2023 08:48 ET
|
Research and Markets
Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "TCR-Therapy - Pipeline Insight, 2023" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...
Global Cyclin-Dependent Kinase Inhibitor Drug Pipeline Research Report 2023: Therapeutics Assessment by Product Type, Stage, Route of Administration, and Molecule Type
November 20, 2023 10:28 ET
|
Research and Markets
Dublin, Nov. 20, 2023 (GLOBE NEWSWIRE) -- The "Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2023" drug pipelines has been added to ResearchAndMarkets.com's offering."Cyclin-Dependent...
Exploring CAR-T Therapy: A New Era in Cancer Treatment
November 14, 2023 04:48 ET
|
Research and Markets
Dublin, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The "CAR-T Therapy- Pipeline Insight, 2023" drug pipelines has been added to ResearchAndMarkets.com's offering. The research report delves into several...
Pasithea Therapeutics Selects PAS-003 Lead Development Candidate, a Humanized Monoclonal Antibody that Targets α5β1 Integrin for the Treatment of both Sporadic and Familial ALS
November 09, 2023 07:59 ET
|
Pasithea
Pasithea Tx (Nasdaq: KTTA) Selects Lead Development Candidate, Humanized mAb that Targets α5β1 Integrin for Treatment of both Sporadic and Familial ALS
China Bispecific Antibodies Market and Clinical Pipeline Insight Report 2023-2028: Akeso are Leading the Way and Gaining Global Recognition for their Innovative Clinical Candidates
November 06, 2023 04:23 ET
|
Research and Markets
Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "China Bispecific Antibodies Market and Clinical Pipeline Insight 2028" drug pipelines has been added to ResearchAndMarkets.com's offering. The...
ImCheck Presented Updated Positive Data from Phase I/IIa EVICTION-2 Trial of ICT01 in Combination with Low-dose IL-2 at SITC 2023
November 03, 2023 14:00 ET
|
ImCheck Therapeutics SAS
ImCheck Presented Updated Positive Data from Phase I/IIa EVICTION-2 Trial of ICT01 in Combination with Low-dose IL-2 at SITC 2023 Interim data from EVICTION-2 study confirms safety and tolerability...
Unlocking the Potential of Biotech Patents: Understanding Patentability and Protection Strategies (December 4-8, 2023)
November 03, 2023 09:13 ET
|
Research and Markets
Dublin, Nov. 03, 2023 (GLOBE NEWSWIRE) -- The "Biotechnology for the Non-Biotechnologist Training Course" conference has been added to ResearchAndMarkets.com's offering. The importance of the...
Acute Myeloid Leukemia (AML) Therapeutics Market Set to Reach $3.7 Billion by 2032: New Pipeline Agents Drive Growth
October 31, 2023 08:58 ET
|
Research and Markets
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The "Acute Myeloid Leukemia (AML) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032" report has been added to ...
World Biologics Contract Development Market Trends Analysis Report 2023-2030: Biopharma Companies Partnering with CDOs Boosts Biologics Contract Development Market
October 27, 2023 04:58 ET
|
Research and Markets
Dublin, Oct. 27, 2023 (GLOBE NEWSWIRE) -- The "Biologics Contract Development Market Size, Share & Trends Analysis Report By Source (Mammalian, Microbial), By Service Type, By Indication...